Differential effects of triamcinolone and bevacizumab in central retinal vein occlusion
- 1 February 2011
- journal article
- Published by Elsevier BV in Canadian Journal of Ophthalmology
- Vol. 46 (1), 88-89
- https://doi.org/10.3129/i10-080
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Observation to Treat Vision Loss Associated With Macular Edema Secondary to Central Retinal Vein OcclusionJAMA Ophthalmology, 2009
- Ranibizumab for Macular Edema Due to Retinal Vein Occlusions: Implication of VEGF as a Critical StimulatorMolecular Therapy, 2008
- Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective studyBritish Journal of Ophthalmology, 2008
- Early Bevacizumab Treatment of Central Retinal Vein OcclusionAmerican Journal of Ophthalmology, 2007
- INTRAVITREAL BEVACIZUMAB INJECTIONS FOR TREATMENT OF CENTRAL RETINAL VEIN OCCLUSIONRetina, 2007
- Intravitreal triamcinolone and bevacizumab combination therapy for macular edema due to central retinal vein occlusion refractory to either treatment aloneEye, 2007